Table 1. Number of tested samples, RSV positivity, subtype prevalence, and demographic data from each year and the whole study period.
2016 n (%) | 2017 n (%) | 2018 n (%) | 2016–18 n (%) | |
---|---|---|---|---|
General data | ||||
Sample n° | 251/632 (40%) | 135/632 (21%) | 246/632 (39%) | 632/632 (100%) |
RSV + | 155/251 (62%) | 80/135 (59%) | 117/246 (48%) | 352/632 (56%) |
RSV - | 96/251 (38%) | 55/135 (41%) | 129/246 (52%) | 280/632 (44%) |
Flu + | 27/251 (11%) | 6/135 (4%) | 14/246 (6%) | 47/632 (7%) |
RSV+ deaths | 6/155 (4%) | 5/80 (6%) | 3/117 (3%) | 14/352 (4%) |
Subtyped samples | 141/155 (91%) | 78/80 (98%) | 113/117 (97%) | 332/352 (94%) |
Subtypes | ||||
RSV-A | 58/141 (41%) | 14/78 (18%) | 108/113 (96%) | 180/352 (51%) |
RSV-B | 80/141 (57%) | 63/78 (81%) | 4/113 (4%) | 147/352 (42%) |
RSV-A and RSV-B | 3/141 (2%) | 1/78 (1%) | 1/113 (1%) | 5/352 (1.4%) |
Demographic data (RSV+) | ||||
Median age (months) | 4 (1–12.0) | 4 (1–10.5) | 3 (1–8.0) | 4 (1–11.0) |
Gender | ||||
Male | 72/155 (46%) | 49/80 (61%) | 61/117 (52%) | 182/352 (52%) |